edwards lifesciences corp
(EW:New York Consolidated)
Transactions by EDWARDS LIFESCIENCES CORP (EW) in the last 6 months
CardioKinetix, Inc. announced that it will receive $37,709,453 in funding on December 5, 2014. The company will issue series F preferred stock and warrants in the transaction. Preferred stock can be convertible into common stock of the company. Each warrant entitles the holder to acquire a series F preferred stock. The company will issue securities pursuant to exemption provided under Regulation D.
Lexington Partners L.P.
New Leaf Venture Partners, L.L.C.
SV Life Sciences Advisers, LLC
SV Life Sciences Fund V
Tekla Capital Management LLC
Tekla Healthcare Investors
Tekla Life Sciences Investors
U.S. Venture Partners
|CR Bard Inc||$168.30 USD||-0.84|
|Endo International PLC||$87.32 USD||+1.72|
|Hologic Inc||$32.68 USD||+0.30|
|Intuitive Surgical Inc||$503.26 USD||+3.26|
|Mettler-Toledo International Inc||$317.52 USD||+3.35|
|View Industry Companies|